
Every Step Counts, But Do You Really Need 10,000?
'For all outcomes, health benefits continued to accrue until around 7000 steps,' said Katherine Owen, PhD, biostatistician at the University of Sydney, Sydney, Australia, who led the review. 'After 7000 steps, benefits either plateaued or there were very small additional benefits.'
Owen and her colleagues reviewed 57 studies and conducted a meta-analysis on 31 of them, examining the relationship between health and physical activity based on daily steps.
The researchers looked at nine different health outcomes: all-cause mortality, the incidence of and deaths from cardiovascular disease, dementia, cancer incidence and mortality, the incidence of type 2 diabetes, depressive symptoms, and falls. Every outcome showed improvement as the amount of daily activity increases, but for most people the benefits tapered off at around 5000-7000 steps per day.
Compared with taking just 2000 steps per day, walking approximately 7000 steps per day reduced all-cause mortality by 47% and decreased the incidence of cardiovascular disease by 25%, of cancer by 6%, of type 2 diabetes by 14%, of dementia by 38%, of depression by 22%, and of falls by 28%.
The study also highlighted that even modest step counts of around 4000 per day were beneficial compared with lower activity of just 2000 steps. 'Every step counts,' Owen said. 'All physical activity is beneficial, but increasing daily steps to around 7000 steps is optimal to improve all health outcomes.'
The conventional wisdom that 10,000 steps per day was the optimal amount has no real basis in fact, said I-Min Lee, MD, epidemiologist at Harvard Medical School, Boston, who was the first to show that the health benefits of daily exercise leveled off after 7500 steps.
'There are quite a bit of data now showing that fewer than 10,000 steps per day brings health benefits,' she said.
Lee said that most studies to date have focused on all-cause mortality and cardiovascular health. The new study expands the evidence to other health outcomes, although the data for some conditions, such as diabetes, are relatively sparse.
Current guidelines for physical activity, such as those from the US Department of Health and Human Services, recommend 150 minutes per week of moderate-to-vigorous physical activity. However, due to lack of evidence at the time of publication, these guidelines do not include daily step targets.
As step tracking technologies have become more common, and data on step-based activity have improved, Lee wants future guidelines to incorporate step targets.
'I don't believe they should replace time targets, since not everybody wants to track their steps,' she said. 'But they should be included.'
Owen and Lee declared having no competing interests.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Journals
15 minutes ago
- Business Journals
Weighted vests may help older adults meet weight loss goals — but bone loss remains an issue
With its latest study of safe weight loss in older adults, Wake Forest University researchers call for regimens that also preserve or strengthen bones. A new randomized clinical trial, led by a team of researchers from Wake Forest University School of Medicine and Wake Forest University, did not find evidence that wearing a weighted vest or engaging in resistance training prevented bone loss in older adults undergoing intentional weight loss. The study, published today in JAMA Network Open, underscores the persistent need for alternative strategies to protect skeletal health in aging populations with obesity. While weight loss is commonly advised to enhance cardiovascular and joint health in older adults with obesity, it may also lead to bone loss, raising the risk of fractures that can diminish both quality and longevity of life. The 12-month INVEST in Bone Health trial enrolled 150 older adults with obesity with a mean age of 66.4 years. Participants were randomized into three groups: weight loss alone, weight loss plus daily weighted vest use and weight loss plus resistance training. All groups achieved similar, significant weight loss (9% to 11.2% of body weight), and adherence to interventions conducted at Wake Forest University was high. The INVEST research team represents a multidisciplinary collaboration of Wake Forest University's departments of Health and Exercise and Statistical Sciences with Wake Forest University School of Medicine's departments of Internal Medicine, Biomedical Engineering, Biostatistics and Data Science, and Radiology. The researchers set out to expand on the findings of a pilot study, in which participants wearing weighted vests seemed to mitigate bone loss that accompanies weight loss in this population. However, all three INVEST study groups experienced a similar rate of significant decreases in hip bone mineral density. 'While we hoped that replacing lost weight externally or increasing mechanical loading through exercise would preserve bone, but our findings show that these strategies alone may not be enough,' said Kristen M. Beavers, the study's corresponding author and professor of internal medicine, section of gerontology and geriatric medicine, at Wake Forest University School of Medicine and research professor of health and exercise science at Wake Forest University. The weighted vest group wore the vest for an average of 7.1 hours per day, replacing approximately 78% of lost weight. The resistance training group attended 71% of the prescribed sessions. Beavers said the study highlights the complexity of managing obesity in older adults, where the benefits of weight loss must be balanced against potential harm to bone health and need to consider alternate or adjuvant countermeasure strategies. An ongoing collaboration between Wake Forest University and Wake Forest University School of Medicine researchers is studying how an osteoporosis drug might help. That study is called the Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial. The INVEST in Bone Health findings are in no way a reason to stop using weighted vests in exercise regimens, Beavers said, and more than half of study participants said they did not mind using them. Studies have shown that, in addition to helping older adults lose weight, such vests also help improve strength and sit-to-stand performance, a key predictor of disability. INVEST was based on a body of research showing that wearing weighted vests during exercise can improve strength, reduce bone loss and improve muscle performance. Bone health is only one predictor of fractures. Beavers said INVEST also points to the potential role of preserving lean muscle mass as a protective factor for bone health. 'Fractures in older adults can be life-altering,' she said. 'Our study reinforces that we need to think beyond traditional exercise and consider new or combined approaches to protect bone during weight loss.' INVEST in Bone Health is the latest in a series of Wake Forest University research studies on safe weight loss for older adults. Scientists there have studied, for instance, the effects of higher-protein diets, resistance training and community-based programs in weight-loss interventions for this population. The timing of such research is vital: It's estimated that 72 million Americans will be age 65 or older by 2030, and the majority of them will be overweight or obese. Moreover, Beavers said the emergence of new and highly effective weight-loss medications, such as Wegovy and Mounjaro, have raised concerns about the bone loss that accompanies rapid weight loss in this population. Developing safe, effective weight-loss protocols for older people is essential to supporting independent living and quality of life. The INVEST research team included Daniel Beavers, associate professor of statistical sciences at Wake Forest University; Barbara J. Nicklas, professor of gerontology and geriatrics at Wake Forest University School of Medicine; Dr. Leon Lenchik, professor of musculoskeletal imaging at Wake Forest University School of Medicine; and Ashley Weaver, associate professor of biomedical engineering at Wake Forest University School of Medicine; and Jason Fanning, associate professor of health and exercise science at Wake Forest University. Learn more about research at Wake Forest University School of Medicine. Atrium Health Wake Forest Baptist is a pre-eminent academic learning health system based in Winston-Salem, North Carolina, and part of Advocate Health. Atrium Health Wake Forest Baptist's two main components are an integrated clinical system with locations throughout the region and Wake Forest University School of Medicine, the academic core of Advocate Health and a recognized leader in experiential medical education and groundbreaking research.
Yahoo
an hour ago
- Yahoo
ASX Penny Stocks To Watch With Market Caps Under A$200M
As the Australian market faces a challenging week with futures down and global tariff tensions looming, investors are keenly observing potential opportunities. Despite its somewhat outdated name, the concept of penny stocks remains relevant for those interested in smaller or newer companies that might offer substantial value. By focusing on firms with solid financial foundations and growth potential, investors can uncover hidden gems within this sector. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.03 A$95.76M ★★★★★★ GTN (ASX:GTN) A$0.57 A$108.68M ★★★★★★ IVE Group (ASX:IGL) A$2.95 A$454.84M ★★★★★☆ West African Resources (ASX:WAF) A$2.35 A$2.68B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.775 A$469.33M ★★★★★★ Regal Partners (ASX:RPL) A$2.92 A$981.78M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.37 A$134.79M ★★★★★★ CTI Logistics (ASX:CLX) A$1.86 A$149.81M ★★★★☆☆ Click here to see the full list of 460 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. CleanSpace Holdings Simply Wall St Financial Health Rating: ★★★★★☆ Overview: CleanSpace Holdings Limited designs, manufactures, and sells respiratory protection products and services for healthcare and industrial markets globally, with a market cap of A$59.48 million. Operations: The company generates revenue of A$17.61 million from its respiratory products segment. Market Cap: A$59.48M CleanSpace Holdings, with a market cap of A$59.48 million, is navigating the challenges of being unprofitable while generating A$17.61 million in revenue from its respiratory products. Despite its negative return on equity and increasing losses over the past five years, it has managed to reduce its debt-to-equity ratio significantly from 51.9% to 14.8%. The company's short-term assets comfortably cover both short- and long-term liabilities, indicating financial stability in the near term. However, the management team lacks extensive experience with an average tenure of 1.9 years, which could impact strategic execution moving forward. Click to explore a detailed breakdown of our findings in CleanSpace Holdings' financial health report. Gain insights into CleanSpace Holdings' future direction by reviewing our growth report. Sandon Capital Investments Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sandon Capital Investments Limited is a publicly owned investment manager with a market capitalization of A$129.27 million. Operations: The company's revenue is derived entirely from Investing Activities, totaling A$23.02 million. Market Cap: A$129.27M Sandon Capital Investments, with a market cap of A$129.27 million, shows financial resilience as its short-term assets (A$167.4M) exceed both short- and long-term liabilities. The company's net profit margins have improved to 70.7%, although it faced negative earnings growth over the past year, contrasting with the industry average growth of 23.4%. Its debt is not well covered by operating cash flow but remains manageable due to more cash than total debt and strong interest coverage by EBIT (9.1x). Despite a low return on equity at 12.6%, its price-to-earnings ratio suggests it may be undervalued compared to the broader Australian market. Dive into the specifics of Sandon Capital Investments here with our thorough balance sheet health report. Explore historical data to track Sandon Capital Investments' performance over time in our past results report. Shaver Shop Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Shaver Shop Group Limited operates as a retailer of personal care and grooming products in Australia and New Zealand, with a market cap of A$193.90 million. Operations: The company's revenue is primarily generated through retail store sales of specialist personal grooming products, amounting to A$218.14 million. Market Cap: A$193.9M Shaver Shop Group Limited, with a market cap of A$193.90 million, operates debt-free and demonstrates financial stability as its short-term assets (A$62.1M) exceed both short- and long-term liabilities. The company has experienced negative earnings growth over the past year (-6.1%), yet forecasts suggest a 7.96% annual growth in earnings moving forward. Despite a decline in net profit margins from 7.1% to 6.7%, Shaver Shop's seasoned management team and high-quality past earnings contribute to its resilience in the market, trading at 54.3% below estimated fair value without significant shareholder dilution recently observed. Click here to discover the nuances of Shaver Shop Group with our detailed analytical financial health report. Evaluate Shaver Shop Group's prospects by accessing our earnings growth report. Summing It All Up Click here to access our complete index of 460 ASX Penny Stocks. Ready For A Different Approach? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CSX ASX:SNC and ASX:SSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Australia's heaviest insect has just been discovered
A new species of giant stick insect has been discovered in Far North Queensland—and scientists believe that it could be Australia's heaviest. James Cook University Adjunct Professor Angus Emmott and south-east Queensland scientist Ross Coupland were able to identify the giant stick insect species after being sent a photo of the insect on social media. The stick insect weighed 44 grams and was 40cm long, making it heavier than the giant burrowing cockroach, which, up until now, had been considered the heaviest insect in Australia. Professor Emmott explained in a statement, 'They live in high-altitude forest, high in the canopy, and unless a bird knocks one down or you get a cyclone or storm that knocks one down we just can't find them up there in the canopy. In the world of invertebrates there is so much we don't know yet.' Two specimens of the species—named Acrophylla alta—have been added to a collection in the Queensland Museum to aid further research. Video transcript A new species of stick insect has been discovered in far north Queensland, and scientists believe that it could be Australia's heaviest. James Cook University adjunct professor Angus Emmett and Southeast Queensland scientist Ross Coupland were able to identify the giant stick insect species after being sent a photo of the insect on social media. The stick insect weighed 44 grammes and was 40 centimetres long, making it heavier than the giant burrowing cockroach, which, up until now, had been considered the heaviest insect in Australia, Professor Emmett explained in a statement. They live in high altitude forest, high in the canopy, and unless a bird knocks one down or you get a cyclone or storm that knocks one down, we just can't find them up there in the canopy. In the world of invertebrates, there is so much we don't know yet. Two specimens of the species named Arophyla alta have been added to a collection in the Queensland Museum to aid further research.